Market Maker Surveillance Report. AUXO, CBLI, ASPS, ADMP, GLBS, ALDX, Losing Stocks With Lowest Price Friction For Thursday, A
April 20, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 5450 companies with "abnormal" market making, 3858 companies with positive Friction Factors and 2031 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Thursday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Auxilio Inc. (NYSE:AUXO), Cleveland BioLabs Inc. (NASDAQ:CBLI), Altisource Portfolio Solutions S.A. (NASDAQ:ASPS), Adamis Pharmaceuticals Corp (NASDAQ:ADMP), Globus Mrtm (NASDAQ:GLBS), Aldeyra Therapeutics (NASDAQ:ALDX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction AUXO $-0.660 -0.11% 137,073 35.84% 163,380 42.72% -26,307 -399 CBLI $-0.870 -0.17% 1,994,814 36.13% 2,319,219 42.00% -324,405 -3,729 ASPS $-18.380 -0.42% 1,820,046 28.61% 2,138,086 33.61% -318,040 -173 ADMP $-0.800 -0.18% 69,088 29.59% 85,823 36.76% -16,735 -209 GLBS $-0.320 -0.12% 154,283 32.71% 210,173 44.56% -55,890 -1,747 ALDX $-0.800 -0.15% 630,002 34.41% 691,258 37.75% -61,256 -766Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows AUXO with a dollar loss Thursday of $-0.66000 and a Friction Factor of -399 shares. That means that it only took 399 more shares of selling than buying to move AUXO lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.
Auxilio Inc. (NYSE:AUXO) - Auxilio, Inc. provides outsourced print management services and IT security consulting services primarily to the healthcare industry in the United States. The company s managed print services assists hospitals and health systems to reduce expenses and create manageable, dependable document image management programs by managing their back-office processes. It also provides IT risk management SaaS solutions; and managed services. In addition, the company sells multi-function device equipment; and offers cyber security professional services, such as penetration testing, cyber security risk assessment, and security program strategy development. It also serves financial institutions, gaming, and other industries. Auxilio, Inc. is based in Mission Viejo, California..
Cleveland BioLabs Inc. (NASDAQ:CBLI) - Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and the Russian Federation. The company s advanced product candidate is entolimod, a Toll-like receptor 5 (TLR5) agonist that is used to prevent death from acute radiation syndrome, and as an oncology drug. It is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics naturally occurring lipopeptides of Mycoplasma, and activates NF-kB pro-survival and immunoregulatory signaling pathways; and Mobilan, a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. In addition, the company develops CBL0137, a small molecule with a multi-targeted mechanism of action used for the treatment of various types of cancer. Cleveland BioLabs, Inc. has strategic partnerships with The Cleveland Clinic and Roswell Park Cancer Institute. The company was founded in 2003 and is headquartered in Buffalo, New York..
Altisource Portfolio Solutions S.A. (NASDAQ:ASPS) - Altisource Portfolio Solutions S.A. operates as a marketplace and transaction solutions provider for the real estate, mortgage, and consumer debt industries in the United States. The company s Mortgage Services segment offers services that span the mortgage and real estate lifecycle to loan servicers, originators, rental property investors, and real estate consumers. This segment provides asset management, origination, insurance, property valuation, and default management services. The company s Financial Services segment offers collection and customer relationship management services. It provides asset recovery management services, such as post-charge-off debt collection; and customer care, technical support, early stage collections, insurance call center, and administrative support services. The company s Technology Services segment offers software and data analytics solutions that facilitate process automation, rules management, controls enforcement, data security, marketplace enablement, and analytics-driven outcomes across the real estate and mortgage lifecycle. It provides loan origination system, borrower application portal, underwriting and quality control solution, and secondary loan trading platform; patented vendor management, marketplace transaction management, and payment management platform; document management platform; data analytics delivery platform; and residential and commercial loan services, and loss mitigation and default services. This segment also offers IT management services, including desktop support, data center support, network management, telephony services, application management, and IT security. The company serves utility companies, commercial banks, servicers, investors, non-bank originators and correspondent lenders, mortgage bankers, insurance companies, and financial services companies, as well as a government-sponsored enterprise. Altisource Portfolio Solutions S.A. was incorporated in 1999 and is headquartered in Luxembourg..
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) - Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, engages in developing and commercializing products in the therapeutic areas of allergy and respiratory disease. Its specialty pharmaceutical product candidates include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-2000 for the treatment of bronchospasms. The company also has various biotechnology product candidates and technologies, including therapeutic vaccine and cancer product candidates that comprise TeloB-VAX (vaccine), APC-100, APC-200, and APC-300, which are under development for the treatment of prostate cancer. In addition, it operates a 503B drug outsourcing facility that provides prescription medications to patients, physician clinics, hospitals, and surgery centers in the United States. The company is headquartered in San Diego, California..
Globus Mrtm (NASDAQ:GLBS) - Globus Maritime Limited, an integrated dry bulk shipping company, provides marine transportation services worldwide. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargoes. As of March 31, 2016, its fleet comprised a total of five dry bulk vessels consisting of one Panamax and four Supramaxes. The company was founded in 2006 and is based in Athens, Greece. Globus Maritime Limited operates as a subsidiary of Firment Trading Limited..
Aldeyra Therapeutics (NASDAQ:ALDX) - .
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net